12) Can the authors speculate if activation of mTOR with insulin might counter any deficit in the signaling pathway, or if there are other appropriate mTOR activation methods that might be beneficial in neurological purine deficiencies? The gene discussed is MTOR; the disease is hyperinsulinemic hypoglycemia, familial, 4.